Issue 7/2020
Content (8 Articles)
Optimal Management of Patients with Advanced NSCLC Harboring High PD-L1 Expression and Driver Mutations
Justin A. Chen, Jonathan W. Riess
Stereotactic Ablative Radiotherapy for Recurrent or Metastatic Gynecological Cancer: Extending Lives?
Tina W. Zhang, David Palma, David D’Souza, Vikram Velker, Lucas C. Mendez
Exercise Training for Cancer Survivors
Calvin K.W. Tong, Benny Lau, Margot K. Davis
Defining Which Patients Are at High Risk for Recurrence of Soft Tissue Sarcoma
Gaya Spolverato, Dario Callegaro, Alessandro Gronchi
Revolutions in treatment options in gastrointestinal stromal tumours (GISTs): the latest updates
Sheima Farag, Myles J. Smith, Nicos Fotiadis, Anastasia Constantinidou, Robin L. Jones
Management of the Axilla after Neoadjuvant Systemic Therapy
Trista J. Stankowski-Drengler, Heather B. Neuman
Clinical Development of PD-1/PD-L1 Inhibitors in Breast Cancer: Still a Long Way to Go
Romualdo Barroso-Sousa, Sara M. Tolaney
Biology and Treatment Paradigms in T Cell Acute Lymphoblastic Leukemia in Older Adolescents and Adults
Anand A. Patel, Joseph Thomas, Alexandra E. Rojek, Wendy Stock